Pharmaceuticals
Our pharmaceuticals portfolio consists of the following categories of oncology and hematology therapeutic agents:
Hematology - Oncology
Bendamustine, 25mg, 100mg
- Powder for concentrate for solution for infusion
- For intravenous infusion
BiCNU, 100mg
- Carmustine for injection USP
- Dehydrated alcohol injection USP as a combipack
Oxaliplatin, 5mg/ml
- Concentrate for solution for infusion
- For intravenous infusion
Azacitidine, 100mg
- Powder for suspension in solution
- For subcutaneous use
Irinotecan HCl, 20mg/ml
- Concentrate for solution for infusion
- For intravenous infusion
Pemetrexed 100mg, 500mg
- Powder for concentrate for solution for infusion
- For intravenous infusion
Docetaxel, 20mg/ml
- Concentrate for solution for infusion
- For intravenous infusion
Doxorubicin, 2mg/ml
- Concentrate for solution for infusion
- For intravenous or intravesical infusion
Paclitaxel, 6mg/ml
- Concentrate for solution for infusion
- For intravenous infusion
Others
Zoledronic Acid 5mg/100ml
- Solution for infusion
- For intravenous infusion
Ceftriaxone 1g, 2g
- Powder for injection
- For intramuscular or intravenous use
Sodium Valporate 100mg/ml
- Solution for injection or infusion
- For intravenous infusion
Fulvestrant 250mg/5ml
- Solution for Injection in Prefilled Syringe
- For intramuscular use
Phenyephrine HClInjection USP 10mg/ml 5mg/100ml
- Concentrate for solution for infusion
- For intravenous infusion
